Patents by Inventor Wei-Guo Su

Wei-Guo Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROAROMATIC COMPOUNDS AND USES THEREOF
    Publication number: 20240092774
    Abstract: Providing heteraromatic compounds and uses thereof. In particular, providing heteraromatic compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same and uses thereof, wherein the variables are as defined in the description.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 21, 2024
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo SU, Weihan ZHANG, Haibin YANG
  • Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
    Patent number: 11896592
    Abstract: Provided are certain triazolopyridines and triazolopyrazines of Formula 1, wherein X, Y, R1, R2, R3, R4 and R5 have any of the meanings described herein; processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: February 3, 2021
    Date of Patent: February 13, 2024
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • PYRIMIDINONE COMPOUNDS AND USES THEREOF
    Publication number: 20240002388
    Abstract: It relates to pyrimidinone compounds and uses thereof. In particular, it relates to pyrimidinone compounds of formula (I), and the pharmaceutical compositions, the preparing methods and the uses thereof, wherein the variables are as defined in the description.
    Type: Application
    Filed: August 17, 2021
    Publication date: January 4, 2024
    Inventors: Wei-Guo SU, Weihan ZHANG, Wei DENG, Haibin YANG
  • ANTI-OX40 ANTIBODY AND USES THEREOF
    Publication number: 20230242657
    Abstract: Provided are an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method thereof and the use for treating OX40-related diseases or conditions.
    Type: Application
    Filed: April 16, 2021
    Publication date: August 3, 2023
    Inventors: Yizhen YANG, Yu CAI, Xiong LI, Lei ZHOU, Weiguo QING, Wei-Guo SU
  • AMIDE COMPOUNDS AND USES THEREOF
    Publication number: 20230174513
    Abstract: The present invention relates to novel amide compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same, and uses thereof, wherein the definition of each symbol is as described in the description.
    Type: Application
    Filed: March 29, 2021
    Publication date: June 8, 2023
    Inventors: Wei-Guo SU, Weihan ZHANG, Haibin YANG
  • ANTI-CD47 ANTIBODY AND USES THEREOF
    Publication number: 20230151110
    Abstract: The present invention provides an anti-CD47 antibody or antigen-binding fragment thereof, a preparation method therefor and the use for treating or preventing CD47-related diseases.
    Type: Application
    Filed: April 11, 2021
    Publication date: May 18, 2023
    Inventors: Yu CAI, Yizhen YANG, Xiong LI, Xianwen YANG, Yongxin REN, Wei-Guo SU
  • ANTI-OX40 ANTIBODY AND USES THEREOF
    Publication number: 20230151105
    Abstract: The present invention provides an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method therefor and the use for treating OX40-related diseases or conditions.
    Type: Application
    Filed: August 18, 2022
    Publication date: May 18, 2023
    Inventors: Yizhen YANG, Yu CAI, Xiong LI, Lei ZHOU, Weiguo QING, Wei-Guo SU
  • CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USE
    Publication number: 20220372005
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof, and/or solvates racemic mixtures, enantiomers, diasteromers, and tautomers thereof, wherein A, R1, R2, R3, R3?, R4, R4?, R5, R6, R7, R8, m, and n are as defined in the detailed description.
    Type: Application
    Filed: May 18, 2022
    Publication date: November 24, 2022
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo SU, Guangxiu DAI, Kun XIAO
  • TRICYCLIC COMPOUNDS AND THEIR USE
    Publication number: 20220315597
    Abstract: Tricyclic compounds and their use are provided. More specifically, tricyclic compounds, pharmaceutical compositions containing them, methods for preparing them, and their use in therapy are also provided.
    Type: Application
    Filed: June 5, 2020
    Publication date: October 6, 2022
    Inventors: Wei-Guo SU, Weihan ZHANG, Jinshui LI
  • Cycloolefin substituted heteroaromatic compounds and their use
    Patent number: 11414390
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof, and/or solvates, racemic mixtures, enantiomers, diasteromers, and tautomers thereof, wherein A, R1, R2, R3, R3?, R4, R4?, R5, R6, R7, R8, m, and n are as defined in the detailed description.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: August 16, 2022
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Guangxiu Dai, Kun Xiao
  • METHODS OF USING SURUFATINIB IN TREATING ADVANCED PANCREATIC AND EXTRA-PANCREATIC NEUROENDOCRINE TUMORS
    Publication number: 20220073642
    Abstract: Disclosed herein are methods of using surufatinib in treating pancreatic and extra-pancreatic neuroendocrine tumors and advanced well-differentiated pancreatic and extra-pancreatic neuroendocrine tumors; the methods disclosed comprise administering to the patient an effective amount of surufatinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 7, 2021
    Publication date: March 10, 2022
    Inventors: Wei-Guo SU, Jing LI
  • Extracts of , methods for preparation and use thereof
    Patent number: 11191798
    Abstract: Disclosed herein are extracts of Andrographis paniculata having highly concentrated active ingredients, preparation methods and medical use for treating autoimmunity and inflammatory disease.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: December 7, 2021
    Assignee: NUTRITION SCIENCE PARTNERS LIMITED
    Inventors: Wei-Guo Su, Xiong Li, Weihan Zhang, Bo Liu, Huaqing Cai, Zhilong Weng, Hongqiang Wang, Zhiyong Yu, Lei Jiang
  • CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USE
    Publication number: 20210363115
    Abstract: The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, and/or solvates, racemic mixtures, enantiomers, diasteromers, and tautomers thereof, wherein A, R1, R2, R3, R3?, R4, R4?, R5, R6, R7, R8, m, and n are as defined in the detailed description of the invention.
    Type: Application
    Filed: September 7, 2018
    Publication date: November 25, 2021
    Applicant: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Guangxiu Dai, Kun Xiao
  • CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USE
    Publication number: 20210163426
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof, and/or solvates, racemic mixtures, enantiomers, diasteromers, and tautomers thereof, wherein A, R1, R2, R3, R3?, R4, R4?, R5, R6, R7, R8, m, and n are as defined in the detailed description.
    Type: Application
    Filed: September 7, 2018
    Publication date: June 3, 2021
    Inventors: Wei-Guo Su, Guangxiu Dai, Kun Xiao
  • CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
    Publication number: 20210154192
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Application
    Filed: February 3, 2021
    Publication date: May 27, 2021
    Applicant: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
    Patent number: 10946014
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: March 16, 2021
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
    Publication number: 20200179377
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Application
    Filed: November 8, 2019
    Publication date: June 11, 2020
    Applicant: Hutchison Medipharma Limited
    Inventors: Guangxiu Dai, Hong Jia, Wei-Guo Su
  • Imidazopyridazine compounds and their use
    Patent number: 10611777
    Abstract: This disclosure provides novel imidazopyridazine compounds of formula (I) and pharmaceutical acceptable salt thereof, pharmaceutical compositions containing them, a process for preparing them, and their practical effect in inhibiting PI3K and potential use in treating a disease responsive to inhibition of PI3K, for example, an inflammatory disease, autoimmune disease or cancer.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: April 7, 2020
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Guangxiu Dai, Weihan Zhang, Wei Deng
  • Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
    Patent number: 10512645
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: December 24, 2019
    Assignee: Hutchinson Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • EXTRACTS OF ANDROGRAPHIS PANICULATA, METHODS FOR PREPARATION AND USE THEREOF
    Publication number: 20190240275
    Abstract: Disclosed herein are extracts of Andrographis paniculata having highly concentrated active ingredients, preparation methods and medical use for treating autoimmunity and inflammatory disease.
    Type: Application
    Filed: November 1, 2017
    Publication date: August 8, 2019
    Inventors: Wei-Guo Su, Xiong Li, Weihan Zhang, Bo Liu, Huaqing Cai, Zhilong Weng, Hongqiang Wang, Zhiyong Yu, Lei Jiang